Volume 20, Issue 4 (Iranian South Medical Journal 2017)
Iran South Med J 2017, 20(4): 399-415 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ostovar A, Fereidooni Z, Ansari A, Haerinejad M, Darabi H, Raeisi A, et al . The Prevalence of Hyperlipidemia Among Older People, Bushehr Elderly Health (BEH) Program. Iran South Med J 2017; 20 (4) :399-415
URL: http://ismj.bpums.ac.ir/article-1-892-en.html
URL: http://ismj.bpums.ac.ir/article-1-892-en.html
Afshin Ostovar1 
, Zahra Fereidooni2 , Amin Ansari2 , MohammadJavad Haerinejad2 , Hossean Darabi2 , AliReza Raeisi2 , GholamReza Heidari2 , Bagher Larijani3 , Neda Mehrdad3 , Gita Shafiee3 , Farshad Sharifi3 , Zhaleh Shadman3 , Mohammad Reza Amini3 , Iraj Nabipour * 4
, Zahra Fereidooni2 , Amin Ansari2 , MohammadJavad Haerinejad2 , Hossean Darabi2 , AliReza Raeisi2 , GholamReza Heidari2 , Bagher Larijani3 , Neda Mehrdad3 , Gita Shafiee3 , Farshad Sharifi3 , Zhaleh Shadman3 , Mohammad Reza Amini3 , Iraj Nabipour * 4
1- The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2- The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
3- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
4- The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran , Inabipour@gmail.com
Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2- The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
3- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
4- The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran , Inabipour@gmail.com
Abstract: (5721 Views)
Background: Life expectancy continues to increase and Iran’s older population grows dramatically. Old age is the strongest risk factor for developing atherosclerotic cardiovascular disease. Hence, effective lipid management can reduce the risk of developing cardiovascular disease.
Materials and Methods: Between March 2013 and October 2014, a total of 3000 men and women aged ≥ 60 years, residing in Bushehr, Iran who participated in Bushehr Elderly Health (BEH) program were evaluated for dyslipidemia. Serum lipid levels in fasting state were measured using Selectra 2 auto analyzer. The cut-offs of cardiovascular risks were derived from the National Cholesterol Education Program (NCEP) guidelines in the United States (Adult Treatment Panel [ATP] III).
Results: The prevalence rates for hypercholesterolemia (≥ 200 mg/dl), high LDL-cholesterol (≥ 130 mg/dl), low HDL-cholesterol (<40 mg/dl) and hypertriglyceridemia (≥ 150 mg/dl) were 48.0%, 42.4%, 29.6%, 35.5%, respectively. The prevalence of dyslipidemia was 87.8% in women and 80.2% in men. The prevalence rate of dyslipidemia was decreased in men with increasing age (p=0.003), however no change was observed in women. A total of 835 subjects (27.8%) used hypolipidemic drugs. The statins were the most common used hypolipidemic drugs. There were significant association between dyslipidemia and traditional cardiovascular risk factors such as diabetes mellitus, hypertension, and obesity (p<0.0001).
Conclusion: Dyslipidemia is a prevalent abnormality among Bushehr‘s older population. Therefore, interventional measures for lipid management are suggested for this population.
Materials and Methods: Between March 2013 and October 2014, a total of 3000 men and women aged ≥ 60 years, residing in Bushehr, Iran who participated in Bushehr Elderly Health (BEH) program were evaluated for dyslipidemia. Serum lipid levels in fasting state were measured using Selectra 2 auto analyzer. The cut-offs of cardiovascular risks were derived from the National Cholesterol Education Program (NCEP) guidelines in the United States (Adult Treatment Panel [ATP] III).
Results: The prevalence rates for hypercholesterolemia (≥ 200 mg/dl), high LDL-cholesterol (≥ 130 mg/dl), low HDL-cholesterol (<40 mg/dl) and hypertriglyceridemia (≥ 150 mg/dl) were 48.0%, 42.4%, 29.6%, 35.5%, respectively. The prevalence of dyslipidemia was 87.8% in women and 80.2% in men. The prevalence rate of dyslipidemia was decreased in men with increasing age (p=0.003), however no change was observed in women. A total of 835 subjects (27.8%) used hypolipidemic drugs. The statins were the most common used hypolipidemic drugs. There were significant association between dyslipidemia and traditional cardiovascular risk factors such as diabetes mellitus, hypertension, and obesity (p<0.0001).
Conclusion: Dyslipidemia is a prevalent abnormality among Bushehr‘s older population. Therefore, interventional measures for lipid management are suggested for this population.
Type of Study: Original |
Subject:
Disorders of Systemic, Metabolic or Environmental Origin
Received: 2017/06/5 | Accepted: 2017/07/16 | Published: 2017/10/28
Received: 2017/06/5 | Accepted: 2017/07/16 | Published: 2017/10/28
References
1. Alineghad M, Matlabi H, Azizi Zeinalhajlou A. Healthy Lifestyle Status among Non- Institutionalized Older People: A Literature Review. Elderly Health Journal. 2015; 1 (2): 52-61.
2. Nabipour I. Megatrends in medicine. Bushehr: Bushehr University of Medical Sciences press, 2014; 127.
3. Kelsey Hall, Pharm.D. Cholesterol lowering therapy in the elderly. CLIPs- Current Literature and Information for Pharmacists. 2015; 19(7):1-2. (Accessed 11 Oct 2017 at https://www.samford.edu/pharmacy/files/CHIPOR/CLIPS/2015/0302Hyperlipidemia%20in%20Older%20Adults.pdf
4. Fakhrzadeh H, Sharifi F. Cardiovascular diseases in the elderly. J Gorgan Uni Med Sci. 2012; 14 (3) :1-9.
5. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J et al; Prospective Studies Collaboration (2007). Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007; 370 (9620): 1829-39.
6. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63(25 Pt B):2889-934. [DOI:10.1016/j.jacc.2013.11.002]
7. Hamilton-Craig, I, Colquhoun, D, Kostner K, et al. Lipid-modifying therapy in the elderly. (2015). Vascular Health and Risk Management, 2015؛ 11, 251–263.
8. Navaei L, Mehrabi Y, Azizi F. Epidemiology of hyperlipidemia, obesity and increased blood pressure in rural areas of Tehran Province. Iran J Endocrinol Metab. 2000; 2(4): 253–262. (Persian) Amiri M, Emami SR, Nabipour I, et al. Risk factors of cardiovascular diseases in Bushehr port on the basis of the WHO Monica project: The Persian Gulf Healthy Heart Project. Iran South Med J. 2004;6(2): 151–161. (Persian)
9. Mohamadi-fard N, Sadri G, Sarraf-zadegan N, et al .The prevalence of cardiovascular risk factors in rural and urban population of Isfahan & Markazi provinces. J Qazvin Univ Med Sci. 2003; 7 (2) :5-14.
10. Azizi F, Rahmani M, Emami H, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1) Soz Praventivmed. 2002;47(6): 408–426. [DOI:10.1007/s000380200008]
11. Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: A population based survey. BMC Cardiovasc Disord. 2007; 7: 32. [DOI:10.1186/1471-2261-7-32]
12. Tabatabaei O, Qorbani M, Samavat T, et al. Prevalence of Dyslipidemia in Iran: A Systematic Review and Meta-Analysis Study. Int J Prev Med. 2014; 5(4): 373–393.
13. Azizi F, Rahmani M, Emami H, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed. 2002; 47(6): 408–26. [DOI:10.1007/s000380200008]
14. Hosseini SR, Cumming RG, Kheirkhah F, et al. Cohort profile: the Amirkola Health and Ageing Project (AHAP). Int J Epidemiol.2014; 43(5): 1393–400. [DOI:10.1093/ije/dyt089]
15. Ostovar A, Nabipour I, Larijani B, et al. Bushehr Elderly Health (BEH) Programme, phaseI (cardiovascular system). BMJOpen 2015;5(12):e009597 [DOI:10.1136/bmjopen-2015-009597]
16. Félix-Redondo FJ, Grau M, Fernández-Bergés D. Cholesterol and Cardiovascular Disease in the Elderly. Facts and Gaps. Aging and Disease. 2013; 4(3): 154-169
17. Karimi F, Rayani M, Akbarzadeh S, et al. Prevalence of hyperlipidemias in adult population (≥19 years) of Bushehr Port; 1999. Iran South Med J. 2000; 3: 98–106. (Persian)
18. Shao H, Quan Chen L, Xu J. Treatment of dyslipidemia in the elderly. Journal of Geriatric Cardiology. 2011; 8(1): 55-64. [DOI:10.3724/SP.J.1263.2011.00055]
19. Schwartz JB. Primary prevention: do the very elderly require a different approach? Trends Cardiovasc Med. 2015; 25(3): 228-39. [DOI:10.1016/j.tcm.2014.10.010]
20. Petersen LK, Christensen K, Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing. 2010; 39(6): 674–680. [DOI:10.1093/ageing/afq129]
21. Manley RW, Weisgraber KH, Farese RW. Disorders of lipid metabolism. in: Larsen PR (chief ed). Williams textbook of endocrinology. 10th ed. Philadelphia: saunders Co; 2003. 1663.
22. Kim CJ, Kim TH, Ryu WS, et al. Influence of menopause on high density lipoprotein-cholesterol and lipids. J Korean Med Sci. 2000; 15(4): 380–386. [DOI:10.3346/jkms.2000.15.4.380]
23. Psaty BM, Anderson M, Kronmal RA, et al. The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study. J Am Geriatr Soc. 2004; 52(10): 1639–1647. [DOI:10.1111/j.1532-5415.2004.52455.x]
24. Nabipour I, Amiri M, Imami SR, et al. Unhealthy lifestyles and ischaemic electrocardiographic abnormalities: the Persian Gulf Healthy Heart Study. East Mediterr Health J. 2008; 14(4):858-868.
25. Bahreynian M, Esmaillzadeh A. Quantity and quality of carbohydrate intake in Iran: A target for nutritional intervention. Iran Med. 2012; 15(10): 648–649.
26. Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease. Circulation. 2007; 115: 450–458. [DOI:10.1161/CIRCULATIONAHA.106.637793]
27. Asia Pacific Cohort Studies Collaboration. Serum triglycerides as a risk factor for cardiovascular disease in the Asia-Pacific region. Circulation. 2004; 110: 2678-2686. [DOI:10.1161/01.CIR.0000145615.33955.83]
28. Melanie G, Bradley R, Christos S, et al. Intramuscular and Liver Triglycerides Are Increased in the Elderly. The Journal of Clinical Endocrinology & Metabolism 2004; 89(8):3864–3871. [DOI:10.1210/jc.2003-031986]
29. Jun M, Foote C, Lv J, et al. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet. 2010; 375(9729): 1875–1884. [DOI:10.1016/S0140-6736(10)60656-3]
30. Catapano AL, Reiner Z, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011; 217 (1): 3–46. [DOI:10.1016/j.atherosclerosis.2011.06.028]
31. Ahmadi SF, Streja E, Zahmatkesh G, et al. Streja DReverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population. J Am Med Dir Assoc. 2015; 16(11):933-939. [DOI:10.1016/j.jamda.2015.07.014]
32. Ghoddosi K, Ameli J, Saadat AR, et al. Dyslipidemia and its relation with smoking in Tehran. Journal of Gorgan University of Medical Sciences. 2006;8(2):55–59.
33. Hassinen M, Lakka TA, Komulainen P, et al. Association of waist and hip circumference with 12-year progression of carotid intima-media thickness in elderly women. International Journal of Obesity . 2007; 31(9): 1406–1411. [DOI:10.1038/sj.ijo.0803613]
34. Fabiana Lucena R, Tarciana Nobre de M, et al. Correlation between indicators of abdominal obesity and serum lipids in the elderly. REV ASSOC MED BRAS. 2013; 59(1):48-55.
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
